Header Logo

Connection

William Traverse to Programmed Cell Death 1 Receptor

Back to Details
This is a "connection" page, showing publications William Traverse has written about Programmed Cell Death 1 Receptor.
William Traverse
Connection Strength
0.628
Programmed Cell Death 1 Receptor
  1. Thomas S, Bae C, Joy-Ann T, Traverse W. Behcet's-like syndrome following pembrolizumab: An immune-related adverse event associated with programmed death receptor-1 inhibitor therapy. J Oncol Pharm Pract. 2020 Jun; 26(4):995-999.
    View in: PubMed
    Score: 0.628
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.